A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files.
A second Johnson & Johnson medicine factory is under scrutiny from federal regulators, while the company struggles to deal with bad publicity and repeated recalls at another factory.
Drugmaker Pfizer Inc. has stopped patient tests of an experimental drug for two types of pain at the request of federal regulators, just weeks after halting its testing in arthritis patients.
DiTEBA Research Laboratories Inc. and Thesis Chemistry Inc. announced a collaboration that will bring together their proven technical expertise in process chemistry, cGMP chemical production and analytical testing.
CIT, an independent preclinical contract research organization (CRO), is now offering the Dried Blood Spot (DBS) technique to its clients worldwide. The new service is in line with CIT’s policy of continuous enhancements to the range it offers its customers.
AAIPharma Services Corp., a biopharmaceutical drug product development and contract manufacturing company, and CritiTech, Inc., a nanotechnology company that improves the delivery of therapeutic molecules, have announced a strategic alliance to expand the reach of the CritiTech technology.
Dolomite has introduced the modular Syringe-based Droplet Starter System, which enables users to produce more than 10,000 monodispersed droplets per second, ranging from Ø20 to 250µm.
Wyatt Technology Corporation, a leader in absolute macromolecular characterization instrumentation and software, announces the launch of its brand new Refractive Index (RI) detection instrument - the Optilab T-rEX.
Novasep, a leading supplier of manufacturing solutions to the life science industries, and instrAction, a manufacturer of innovative chromatographic stationary phases for API purification processes, announced that they have entered into a strategic alliance.
BioFocus and the University of Bristol announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain).
Researchers at Duke University Medical Center have identified a mechanism that could explain how patients move into the worst phase of chronic myelogenous leukemia (CML).
Take a skin cell from a patient with Type 1 diabetes. Strip out everything that made it a skin cell, then reprogram it to grow into a colony of pancreatic beta cells.
Amgen announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events (SREs) in patients with cancer.
Abbott presented 48-week findings comparing an HIV regimen of its protease inhibitor, Kaletra, and Merck's integrase inhibitor, Isentress, to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors in Truvada in antiretroviral-naive adult patients.
One day your annual flu shot could come in the mail. At least that's the hope of researchers developing a new method of vaccine delivery that people could even use at home: a patch with microneedles.